Examples include hERG (KCNH2) for QT prolongation, α1A adrenergic receptor (ADRA1A) modulation for arrhythmia (agonists) or orthostatic hypotension (antagonists), and dopamine D1 (DRD1) antagonism for dyskinesia and tremors7. The gene discussed is KCNH2; the disease is drug-induced dyskinesia.